IDO1 and depressive symptom measurement: Regarding CCH-induced neurodegeneration, evidence from preclinical studies demonstrated that inhibition of IDO is protective against neuroinflammation in Parkinson’s disease, Alzheimer’s disease, and depression [83,84,85].